Key Takeaways
- • Novo Holdings, the $37 billion investment arm of Denmark's Novo Nordisk Foundation, is actively building a roster of homegrown general partners in Asia while expanding regional headcount, according to managing partner Amit Kakar.
- • The firm's Asia investment strategy encompasses India, China, and Southeast Asia, with a focus on deploying capital across USD 100-500+ investment ranges through its Singapore-based team.
- • Novo Holdings recently participated in a private equity continuation fund investment in Asia alongside KKR, signaling commitment to larger-scale deal participation in the region.
- • The organization is simultaneously pursuing "planetary health" portfolio expansion, targeting energy transition and broader ESG-aligned opportunities alongside traditional private equity exposure.
- • Novo Holdings maintains a team of 235 professionals globally with diverse backgrounds, with dedicated Europe and US operations working collaboratively with the Asia investment division.
Summary
Denmark's Novo Holdings is accelerating its institutional presence in Asia through a dual-pronged strategy focused on developing regional general partner relationships and scaling operational headcount in key markets. According to Amit Kakar, the managing partner overseeing the initiative, the $37 billion investment vehicle—which manages the Novo Nordisk Foundation's capital—is actively recruiting and partnering with homegrown Asia-based GPs rather than relying exclusively on established Western managers.
The firm's geographic targeting spans India, China, and Southeast Asia, with operations centralized through a Singapore-based investment team. This regional hub maintains direct collaboration with Novo Holdings' European and U.S. divisions, enabling coordinated deal sourcing and portfolio management. The manager deploys capital across a broad investment thesis, targeting deals in the USD 100-500 million range and above, with flexibility for both smaller and larger commitments depending on opportunity quality.
Recent activity demonstrates Novo Holdings' willingness to participate in continuation fund structures alongside leading global sponsors. The firm invested in a private equity continuation fund in Asia in partnership with KKR, underscoring its confidence in the region's exit environment and secondary market dynamics. This positioning aligns with broader institutional investor trends toward direct Asia-Pacific exposure rather than reliance on non-regional intermediaries.
Beyond traditional private equity, Novo Holdings is expanding its "planetary health" portfolio, which emphasizes energy transition, sustainability, and ESG-aligned opportunities. This thematic overlay reflects the foundation's mission-driven mandate while capturing the rapid capital flows toward climate-related and planetary health infrastructure across Asian markets. The combination of sector-specific targeting and GP relationship-building positions Novo Holdings to capitalize on Asia's maturing private capital ecosystem while maintaining alignment with its philanthropic foundation's investment principles.
The firm's geographic targeting spans India, China, and Southeast Asia, with operations centralized through a Singapore-based investment team. This regional hub maintains direct collaboration with Novo Holdings' European and U.S. divisions, enabling coordinated deal sourcing and portfolio management. The manager deploys capital across a broad investment thesis, targeting deals in the USD 100-500 million range and above, with flexibility for both smaller and larger commitments depending on opportunity quality.
Recent activity demonstrates Novo Holdings' willingness to participate in continuation fund structures alongside leading global sponsors. The firm invested in a private equity continuation fund in Asia in partnership with KKR, underscoring its confidence in the region's exit environment and secondary market dynamics. This positioning aligns with broader institutional investor trends toward direct Asia-Pacific exposure rather than reliance on non-regional intermediaries.
Beyond traditional private equity, Novo Holdings is expanding its "planetary health" portfolio, which emphasizes energy transition, sustainability, and ESG-aligned opportunities. This thematic overlay reflects the foundation's mission-driven mandate while capturing the rapid capital flows toward climate-related and planetary health infrastructure across Asian markets. The combination of sector-specific targeting and GP relationship-building positions Novo Holdings to capitalize on Asia's maturing private capital ecosystem while maintaining alignment with its philanthropic foundation's investment principles.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.